TTNP - Titan Pharmaceuticals, Inc. (de)
IEX Last Trade
5.97
0.307 5.134%
Share volume: 148,836
Last Updated: Fri 30 Aug 2024 05:46:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$5.66
0.31
5.41%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
| Report Date | 2022-05-16 | 2022-08-11 | 2022-11-14 | 2023-03-31 | 2023-05-15 | |
| Cash flow financing | 4.981 M | 3.000 K | 0.000 | 0.000 | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -2.964 M | -1.767 M | -1.873 M | -1.579 M | -1.899 M | |
| Net income | -2.540 M | -2.462 M | -2.638 M | -2.566 M | -1.675 M | |
| Depreciation | 52.000 K | 51.000 K | 48.000 K | 45.000 K | 43.000 K | |
| Changes in inventories | 293.000 K | 469.000 K | 460.000 K | 106.000 K | 106.000 K | |
| Changes in receivables | 218.000 K | 101.000 K | 49.000 K | 36.000 K | 8.000 K | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | -8.887 M | -6.964 M | -4.962 M | -3.251 M | -1.542 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 8.138 M | 6.420 M | 4.450 M | 2.937 M | 1.136 M |